Share Name Share Symbol Market Type Share ISIN Share Description
Batm Advanced Communications LSE:BVC London Ordinary Share IL0010849045 ORD ILS0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -1.60% 15.375p 15.25p 15.50p 15.50p 15.25p 15.50p 70,319 16:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 65.9 -7.7 -2.2 - 61.98

BATM Advanced Communications (BVC) Latest News

More BATM Advanced Communications News
BATM Advanced Communications Takeover Rumours

BATM Advanced Communications (BVC) Share Charts

1 Year BATM Advanced Communications Chart

1 Year BATM Advanced Communications Chart

1 Month BATM Advanced Communications Chart

1 Month BATM Advanced Communications Chart

Intraday BATM Advanced Communications Chart

Intraday BATM Advanced Communications Chart

BATM Advanced Communications (BVC) Discussions and Chat

BATM Advanced Communications Forums and Chat

Date Time Title Posts
22/10/201615:25Batm Advanced - A New Beginning14,287
30/8/201617:01BATM - Broadband bright future22,405
09/8/201322:00batm great trading statement41
14/5/201120:07SHARE TIP OF THE DECADE79

Add a New Thread

BATM Advanced Communications (BVC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all BATM Advanced Communications trades in real-time

BATM Advanced Communications (BVC) Top Chat Posts

BATM Advanced Communications Daily Update: Batm Advanced Communications is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker BVC. The last closing price for BATM Advanced Communications was 15.63p.
Batm Advanced Communications has a 4 week average price of 16.32p and a 12 week average price of 17.35p.
The 1 year high share price is 19.75p while the 1 year low share price is currently 12.75p.
There are currently 403,150,820 shares in issue and the average daily traded volume is 54,293 shares. The market capitalisation of Batm Advanced Communications is £61,984,438.58.
fse: >stesh......yes most of us are thoroughly frustrated with this company and its share price. The problems stem from the fact that they had to totally re invent themselves. Until that is seen in the bottom line there is really no reason for anyone to rush in to accumulate them and anytime someone needs out the lack of buyers flattens the share price. The medical arm is from all that we can see making progress,but the Telco division has bet heavily on SDN and the cloud and we have yet to see them really nail down decent contracts here. So many false dawns have eroded confidence that they will ever get out of the blocks (so to speak !) Honestly I feel that the share price in no way reflects the progress that they have made but thats not much consolation as the share price tanks. As you say if you dump them they will likely rocket as they have all the hallmarks of an old fashioned multi bagger. Again I know of no reason for the slide other than indifference to them ...... Edit.... The falls today are on volumes of under 1,000 GBP traded ... thats what happens if MM's cant find buyers...LOL
paulisi: Another set of results that have disappointed. I suspect the markets predicted a higher turnover figure and a small return to profit. There is optimism for the second half of the year, but we hear this on a regular basis and nothing comes to fruition. Until we hear positive numbers and a re-introduction of the dividend, the share price will remain static. The long term plan must be to split the business into two and sell off one of the divisions.
fse: Links..... hTTp:// hTTp:// hTTp:// hTTp:// Some background and an idea how long it takes to get these applications for actual sale in the marketplace BATM's Adaltis gets CE certification for HCV screening kit Company Links BATM Advanced Communications Limited 2nd May 2012 BATM Advanced Communications subsidiary Adaltis has received CE certification for its HCV (Hepatitis C) screening kit. The kit is a fourth generation Enzyme Immunoassay kit for the determination of antibodies to Hepatitis's C virus in human plasma or serum. Testing in external, independent labs has shown performance results of 100% for diagnostic sensitivity and 99.5% for diagnostic specificity, clearly marking this screening kit as the top of its class. This level of accuracy will ensure that patients receive reliable diagnoses and that laboratories are spared the significant and needless expense of repeat testing. At 8:22am: (LON:BVC) BATM Advanced Communications share price was 0p at 15.25p Early 2015 news EIAgen Hepatitis C Virus (microELISA) Granted Licence for Sales in China ADALTIS S.r.l. is pleased to announce that it has been granted a license by the China Food and Drug Administration of People’s Republic of China for the importation, marketing and sale in China of its diagnostic kit for hepatitis C (‘EIAgen HCV’), which it identifies by detecting antibodies to the virus using a reliable and cost effective microELISA screening technique.
james dean: THE POST What’s Ahead for BATM Advanced Communications Ltd After Reaching 52-Week Low? by Post Staff Writer — June 21, 2016 The stock of BATM Advanced Communications Ltd (LON:BVC) hit a new 52-week low and has GBX 12.24 target or 11.00% below today’s GBX 13.75 share price. The 7 months bearish chart indicates high risk for the GBX 54.83M company. The 1-year low was reported on Jun, 21 by If the GBX 12.24 price target is reached, the company will be worth GBX 6.03 million less. The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 6.78% or GBX 1 on June 21, hitting GBX 13.75. About 11.89 million shares traded hands or 19411.63% up from the average. BATM Advanced Communications Ltd (LON:BVC) has declined 20.81% since November 18, 2015 and is downtrending. It has underperformed by 22.63% the S&P500. BATM Advanced Communications Ltd. is an Israel firm engaged in the development, production and marketing of medical products, as well as data communication products. The company has a market cap of 54.83 million GBP. The Firm has two operating divisions: Telecommunications and BATM Medical. It currently has negative earnings. The Telecommunications division develops and offers telecom network solutions, IP surveillance solutions, software services and Cyber Security solutions. BATM Advanced Communications, receive a concise daily summary of the latest news and analysts’ ratings with’;s FREE daily email newsletter.
woody888: Very odd over the past couple of days. There has been excellent and positive news flow recently. I am interested in the cyber security division and the ATCA platform enhancement solution; huge volumes for this share today and a share price heading south, it is clearly not referendum related but must be something else, and I will hold off increasing holding/investing in this company until some clarity is established on what is driving this share price decline. Still maintain that there is HUGE potential in this company at this moment in time. Polemically and supporting the potential notion a takeover could be coming....
fse: INVESTMENT OVERVIEW BATM Advanced Communications Ltd rides currency headwinds Share 12:00 06 Jun 2016 BATM's biomedical arm became profitable for the first time BATM Advanced Communications Ltd rides currency headwinds INVESTMENT OVERVIEW: BVC THE BIG PICTURE BATM has bought Green Lab Hungary Engineering, which develops and distributes analytical instruments Laboratory and telecom network technology group BATM Advanced Communications Ltd (LON:BVC) said a maiden profit in its biomedical arm had driven it back into the black. BATM revealed the biomedical division, which makes up 54% of BATM's sales, had become profitable for the first time in the group's history. The division's gross margin improved to 25% versus 23% in 2014, its distribution business expanded in absolute terms in all markets and its diagnostics unit reached break-even. The group made a US$700,000 adjusted operating profit in the year to December 31 against a US$1mln loss a year ago. BATM's telecom division started showing a recovery as it reported a US$300,000 operating profit in the second half against a US$900,000 loss last time. New products and technologies also continued to increase sales and replace legacy products, positioning the group to further improve revenues and gross margins. Group pre-tax earnings before interest, depreciation and amortisation were US$2.5mln against US900,000mln a year ago. Constant currency revenue rose to US$111.7mln from US$109.2mln beforehand. WHAT THE CHIEF EXECUTIVE SAID On the performance in 2015... Zvi Marom said: "We believe we have turned a corner and transformed the group in both our divisions. "In particular, the diagnostics unit reached a major milestone by reaching break-even for the first time and also increased its production capacity, for both instruments and reagents, to cater for anticipated demand in 2016. On the outlook... "Looking ahead, we entered 2016 in a stronger position, with a higher backlog, than at the same time in the prior year. We expect to maintain the momentum of last year. "The board expects to achieve growth in line with market expectations." ABOUT THE COMPANY Currency head-winds ruffled BATM in 2015, but the group is confident biomedical business advances and a telecoms recovery will help it ride the turbulence. Foreign exchange volatility weighed on the group's reported revenue by US$14.6mln, although constant currency revenue lifted 2.3% to US$111.7mln. But BATM racked up its first profit in its bio-medical division and pointed to a recovery in its telecoms arm as evidence that business is on track. The bio-medical division, which is involved in developing diagnostic systems, biological waste products and analytical instruments, increased its gross margin to 25% against 23% a year earlier. The distribution business grew, in absolute terms, in all markets and its diagnostic arm reached break-even. It signed an agreement with Gamida for Life to establish a joint venture company, Ador, to develop and market a unique rapid-results molecular diagnostics system, and earlier this year, BATM announced the acquisition of Green Lab Hungary Engineering Ltd, which develops and distributes analytical instruments, for US$3.8mln. Its telecoms division showed signs of getting back on track after tussling with lower revenue and a stock write-off related to legacy products. The business achieved a second-half operating profit due to tight cost control, resulting in a full-year adjusted operating profit of US$300,000, compared to a US$900,000 loss in the second half of 2014. It won telecoms-related contracts in Asia Pacific and the US and netted a government deal potentially worth US$10mln or more in the growing cyber-security market. In June 2016, telecoms subsidiary Telco also completed a 10 Gigabit Ethernet (GE) installation for a major telecoms group in south-east Asia. The contract was a follow on from an earlier network hTTp:// modernisation upgrade to 4G/LTE services. At network capacity of 10GE, the telecoms group can support more broadband traffic and offer higher quality hTTp:// services, BATM said. Adjusted basic earnings per share were 0.02 cents against a loss per share of 0.36 cents in 2014. Cash outflow was US$2.2mln against US$5.3mln last time. At the end of 2015, the group had cash and cash equivalents and financial assets of US$23.8mln versus US$34.9mln a year earlier. Marom said: "We expect to maintain the momentum of last year across our divisions, supported by our recent Green Lab acquisition. "We are particularly excited by the interest being received by Ador, our diagnostics joint venture company with Gamida." WHAT THE SHARE PRICE DID Shares in the group were 16.47p in mid-morning trading in London. WHAT THE BROKERS SAID Broker and adviser to BATM, Shore Capital, noted that the balance sheet remained strong with liquidity of about US$23.8mln and net cash of some US$19mln. It expects biomedical to make up more of the company's revenues in 2016, although currency head-winds are likely to continue to weigh. It added that positive signs continue to emerge of improving market traction in telecoms and cyber activities appeared to be gaining traction. "We note the government sole supplier agreement for a security solution signed last year – a strong reference point for future sales, in our view," the broker's Robin Speakman said. Speakman added that Shore was keeping its forecast of a steady improvement in profit on recovering sales at an underlying constant currency level. He said: "We expect positive news flow on strategic development to continue."
james dean: BATM Advanced Communications Ltd Gaps Up; Strong Momentum for Buyers Blanche SilvaMay 23, 2016 The stock of BATM Advanced Communications Ltd (LON:BVC) gapped up by GBX 0.075 today and has GBX 35.12 target or 122.00% above today’s GBX 15.82 share price. The 5 months technical chart setup indicates low risk for the GBX 64.27M company. The gap was reported on May, 24 by If the GBX 35.12 price target is reached, the company will be worth GBX 78.41M more. Gaps up are useful for using as a support level and to some extent as a tradeable event. If investors already hold the stock and experience a price gap up, then its usually a good idea to hold the stock for a stronger up move. Back-tests of these patterns indicate that two-thirds of the times the stock performance improves after the gap. The area gaps close 89% of the time, the breakaway gaps, 2%, the continuation gaps 4% and the exhaustion gaps 61%. The stock increased 0.48% or GBX 0.07 on May 23, hitting GBX 15.82. About 22,500 shares traded hands. BATM Advanced Communications Ltd (LON:BVC) has declined 17.42% since October 21, 2015 and is downtrending. It has underperformed by 18.83% the S&P500. BATM Advanced Communications Ltd. is an Israel firm engaged in the development, production and marketing of medical products, as well as data communication products. The company has a market cap of 64.27 million GBP. The Firm has two operating divisions: Telecommunications and BATM Medical. It currently has negative earnings. The Telecommunications division develops and offers telecom network solutions, IP surveillance solutions, software services and Cyber Security solutions.
fse: Another mixed bag ….. Here’s my take on the company FWIW and how I see it from an investors perspective. I have highlighted what I see as pivotal points. BATM Telco report as a group but also give figures for the 2 divisions. Its better to look at them separately and then together Medical division: Bio division went into operating profit in local currency terms but also a small profit in $US terms. In US$ terms they went from FY 2014 $1.5M loss to FY 2015 .2M profit. That’s a 3% to 4% growth rate in US$ (reporting currency) Its true that currency issues have once again played a part. In operating currency terms the growth rate would be closer to 12% My take on this is that this is broadly speaking accurate. Gross margins across the board increased from 23% to 25%. This may not sound like much but it is significant and it’s in the right direction. The Diagnostic element and reagents now I understand “in house” have experienced growth and this is something to watch, the group reported an improvement in gross margins on reagents from 21% in 2014 to 34% in 2015. Comment: This is actually a very significant improvement not so much in overall sales growth which is OK but not stellar. What’s to like is that this is being processed in house so they have control over supplies and have dramatically improved their margins. One caveat may be that to get to this point they have only been able to sell product commensurate with their ability to manufacture product which has limited their volume. The company made changes to manufacture in 2015 to essentially double their capacity. The way forwards in this department looks solid and the company understandably appear bullish on these prospect. We are told that the distribution business makes up 67% of the Medical division revenue. There are other sides to the medical division which appear to be in a 3 steps forwards 2 backwards position. Its hard to gauge the actual value of some of these departments. I don’t think they are having trouble just lethargic and I don’t think there is anything in there that would hugely alter the fortunes for the Medical division or the group as a whole. Comment: My best estimate is that the medical division is indeed making progress. Remember these results are always lagging indicators. I would expect that they can improve on these figures going forwards and that’s essentially what they are saying. I have no good reason to dispute this claim. Telco Division Results are inline with expectations for the Telco Division and it looks as if we interpreted the situation fairly accurately. Telco systems are concentrating on Tier 1 clients and reducing legacy business. Cost cutting is keeping the division from being a drain on the group. Comment: There is a lot written and posted on this thread regarding the Telco division, suffice to say that they have changed the direction of the group. This has taken a lot longer than anyone had hoped for. Even now uptake to SDN and NFV, an integral part of the company’s vision , is lethargic at best. I have to go a big neutral on the Telco division particularly over the next 12mths to 18 mths as they seem to be having to do an exorbitant amount of work and presentations to get a foot in this door. Personally I do feel there is a real option to sell the Telco arm. If they sell the Telco division it will probably boost the share price significantly. The argument for holding onto the division is that they have controlled costs and they can afford to wait it out. Bottom line is that the Telco results were predictably anemic and I do not expect to see any major contribution from this division any time soon. Group as a whole is actually not doing that badly. The backdrop of news is favourable. They acquired Green Lab, which did reduce their cash position. They have more than sufficient cash going forwards. They also lets not forget own their own real estate. I would say the current share price reflects what is going on currently and has zero in there for potential. Management tone is understandably robust but then again they are looking forwards and these results are what’s already happened
james dean: Price Target Update On Shares Of BATM Advanced Communications Ltd. (LON:BVC) A number of investment brokers have recently updated their price targets on shares of BATM Advanced Communications Ltd. (LON:BVC). According to the latest broker reports 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”. Most recent broker ratings 24/08/2015 – BATM Advanced Communications Ltd. had its “Corporate” rating reiterated by analysts at FinnCap. They now have a GBP 20.00p price target on the stock. The share price of BATM Advanced Communications Ltd. (LON:BVC) was down -1.39% during trading on 17/12/2015, with a day high of 17.80. 45000 shares were traded on 17/12/2015. The stock’s 50 day moving average is 18.72 and its 200 day moving average is 17.75. The stock’s market capitalization is 71.56M. BATM Advanced Communications Ltd. has a 52-week low of 11.65 and a 52-week high of 20.75. BATM Advanced Communications Ltd. is an Israel-based company engaged in the development, production and marketing of medical products, as well as data communication products. The Company has two operating divisions: Telecommunications and BATM Medical. The Telecommunications division develops and offers telecom network solutions, IP surveillance solutions, software services and Cyber Security solutions. The Telecommunications offers its products to telecom operators in developed markets. BATM Medical is a manufacturer and developer of laboratory diagnostics, including in-vitro diagnostic systems and reagents to detect viral infections, to diagnose immune system diseases and for the measurement of human hormone responses. BATM Medical, which focuses on developing countries in Eastern Europe and Asia, also manufactures sterilizers and medical waste management solutions, and distributes brands of other diagnostic equipment suppliers to emerging market countries.
nilip: Just looked at BVC on the Tel-Aviv exchange. Intraday chart shows BVC rising ~ 35% from 90 - 120 ! ... and then settle back down with a small rise. Not sure what that was all about, but certainly a spell of excitement for the BVC share price over there it seems.
BATM Advanced Communications share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161023 09:41:59